Syntec Optics (OPTX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
29 Nov, 2025Executive summary
The 2025 Annual Meeting will be held virtually on January 20, 2026, with shareholders able to vote online or by proxy.
Key proposals include electing two directors, ratifying the auditor, approving RSU grants, and amending the Certificate of Incorporation.
The Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Voting matters and shareholder proposals
Shareholders will vote on electing two directors, ratifying CBIZ, Inc. as auditor, approving RSU grants under the 2023 Equity Incentive Plan, and amending the Certificate of Incorporation.
Voting can be done online, by phone, or by mail, with a quorum set at a majority of outstanding shares.
The Board unanimously recommends voting FOR all proposals.
Broker non-votes will not affect most proposals except the amendment to the Certificate of Incorporation, where they count as AGAINST.
Board of directors and corporate governance
The Board consists of five directors in three staggered classes; two are up for election for terms expiring in 2028.
Nominees Wally Bishop and Albert A. Manzone bring expertise in regulatory compliance, financial oversight, strategic vision, and M&A.
The Board includes independent directors and meets quarterly, with all members attending at least 75% of meetings in 2024.
Board diversity matrix shows all five directors are male and white.
Latest events from Syntec Optics
- Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 202513 Feb 2026 - Gross margin rose to 29% in H1 2025 as sales and adjusted EBITDA improved year-over-year.OPTX
Q4 202413 Feb 2026 - Q1 2025 net income turned positive on 13% sales growth and improved margins.OPTX
Q1 202513 Feb 2026 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 202512 Feb 2026 - Q2 sales up 12% sequentially, product growth strong, and Q3 outlook robust.OPTX
Q2 20242 Feb 2026 - Q3 sales up 19% year-over-year, but higher costs led to a net loss; Q4 outlook is positive.OPTX
Q3 202413 Jan 2026 - Virtual meeting to vote on directors, auditor, RSUs, and governance amendments; board recommends approval.OPTX
Proxy Filing8 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and RSU grants at the virtual annual meeting.OPTX
Proxy Filing2 Dec 2025